Tenax Therapeutics, Inc. (TENX)

USD 5.52

(-4.99%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 7570.00 113.33 Thousand 108.98 Thousand 114.74 Thousand 107.27 Thousand 9015.00
Gross Profit -7570.00 -113.33 Thousand -108.98 Thousand -114.74 Thousand -107.27 Thousand -9015.00
Operating Expenses 8.23 Million 11.05 Million 32.72 Million 9.86 Million 8.55 Million 6.89 Million
Selling, General and Administrative Expenses 5 Million 5.67 Million 7.58 Million 5.3 Million 5.08 Million 5.65 Million
Research and Development Expenses 3.22 Million 5.37 Million 25.14 Million 4.56 Million 3.47 Million 1.23 Million
Other Expenses - 9191.00 254.83 Thousand 18.16 Thousand 160.9 Thousand 79.83 Thousand
Cost and Expenses 8.23 Million 11.05 Million 32.72 Million 9.86 Million 8.55 Million 6.89 Million
Operating Income -8.23 Million -11.05 Million -32.72 Million -9.86 Million -8.55 Million -6.89 Million
Interest Expense 23.96 Thousand 4443.00 949.00 1627.00 - -
Income Tax Expense - -4748.00 255.78 Thousand 19.79 Thousand -64.58 Thousand -79.83 Thousand
Earnings before Tax -7.71 Million -11.04 Million -32.47 Million -9.85 Million -8.39 Million -6.81 Million
Net Income -7.71 Million -11.04 Million -32.73 Million -9.87 Million -8.39 Million -6.73 Million
Earnings Per Share Basic -31.09 -600.46 -2545.11 -1523.80 -27.10 -7359.14
Earnings Per Share Diluted -31.04 -600.46 -2545.11 -1523.80 -27.10 -7359.14
Weighted Average Shares Outstanding 248 Thousand 18.39 Thousand 12.86 Thousand 6478.00 309.77 Thousand 915.00
Weighted Average Shares Outstanding (Diluted) 248.44 Thousand 18.39 Thousand 12.86 Thousand 6478.00 309.77 Thousand 915.00
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -8.22 Million -10.93 Million -32.36 Million -9.73 Million -8.28 Million -6.88 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts